evidence table

Cashew Lipid Profile Randomized Trial Evidence Table

Structured evidence table for Cashew Lipid Profile Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Cashew Lipid Profile Randomized TrialPURPOSE: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern in Asia, where dietary patterns differ significantly from those in Mediterranean regions.4Tan VMH (2026)Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Cashew Lipid Profile Randomized TrialCONCLUSION: The AMED represents a culturally adapted, nutritionally coherent, and sensory-acceptable interpretation of the MedDiet for Asian populations.4Tan VMH (2026)Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Cashew Lipid Profile Randomized TrialAlthough the Mediterranean Diet (MedDiet) is recommended for MASLD management, its adoption in Asia remains limited.4Tan VMH (2026)Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
topicCashew Lipid Profile Randomized Trial
claimPURPOSE: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern in Asia, where dietary patterns differ significantly from those in Mediterranean regions.
evidence level4
citationTan VMH (2026)
sourceDevelopment of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
topicCashew Lipid Profile Randomized Trial
claimCONCLUSION: The AMED represents a culturally adapted, nutritionally coherent, and sensory-acceptable interpretation of the MedDiet for Asian populations.
evidence level4
citationTan VMH (2026)
sourceDevelopment of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
topicCashew Lipid Profile Randomized Trial
claimAlthough the Mediterranean Diet (MedDiet) is recommended for MASLD management, its adoption in Asia remains limited.
evidence level4
citationTan VMH (2026)
sourceDevelopment of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Learn next

Related evidence and supplement guides

GuideCashew Lipid Profile Randomized Trial: What the Evidence SaysCashew Lipid Profile Randomized Trial has 1 source documents in the current Migaku evidence data...GuideAlmond Lipid Profile Randomized Trial: What the Evidence SaysAlmond Lipid Profile Randomized Trial has 2 source documents in the current Migaku evidence data...GuidePistachio Lipid Profile Randomized Trial: What the Evidence SaysPistachio Lipid Profile Randomized Trial has 2 source documents in the current Migaku evidence d...GuideWalnut Lipid Profile Randomized Trial: What the Evidence SaysWalnut Lipid Profile Randomized Trial has 1 source documents in the current Migaku evidence data...AnswerDoes Cashew Lipid Profile Randomized Trial work?Cashew Lipid Profile Randomized Trial has evidence relevant to strength of evidence and what the...AnswerIs Cashew Lipid Profile Randomized Trial safe?Cashew Lipid Profile Randomized Trial has evidence relevant to safety, limits, and clinician-dis...AnswerWhat does the evidence say about Cashew Lipid Profile Randomized Trial?Cashew Lipid Profile Randomized Trial has evidence relevant to benefits, uncertainty, and practi...AnswerDoes Almond Lipid Profile Randomized Trial work?Almond Lipid Profile Randomized Trial has evidence relevant to strength of evidence and what the...

Source documents

  1. Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).